FDA Inspection 580980 — Biocryst Pharmaceuticals, Inc.
The FDA completed an inspection of Biocryst Pharmaceuticals, Inc. on May 26, 2009 in Birmingham, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 26, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Birmingham, AL (United States)